Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia

Eastern Mediterranean Health Journal

Volumn 12, Issue 1-2, 2006, Pages 204-210

  Al Kubaisy, Waqar A ^a   Al Naib, K T ^a   Habib, M ^a  

^a Al Nahrain University College of Medicine   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INFECTION CONTROL; IRAQ; MAJOR CLINICAL STUDY; RANDOM SAMPLE; RNA ANALYSIS; SEROPREVALENCE; THALASSEMIA; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DONOR SELECTION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALS, TEACHING; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; INFECTION CONTROL; IRAQ; POPULATION SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; THALASSEMIA; URBAN HEALTH;

EID: 33748414063     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Minola E et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood, 2002, 99(12):4588-91.
2. Al-Sheyyab M, Batíeha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and HIV markers in multi-transfused patients. Journal of tropical pediatrics, 2001, 47:239-42.
3. Al-Hawsawi ZM. Prevalence of HCV antibody. Annals of Saudi medicine, 2000, 20:488-9.
4. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Annals of internal medicine, 1999, 125:658-68.
5. Garson JA et al. Demonstration of viraemia patterns in haemophilics treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet, 1990, 336:1022-5.
6. Simmonds P et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology, 1994, 19(5):1321-4.
7. Prati D et al. A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous β-thalassemia. Blood, 1998, 92:3460-6.
8. Al-Kubaisy WA. Epidemiologic and genotypic distribution of hepatitis C in Iraqi pregnant women. PhD thesis, 1998.
9. Kebudi R et al. Seroprevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Medical and pediatric oncology, 2000, 34:102-5.
10. Chung JL et al. Hepatitis C and G virus infections in polytransfused children. European journal of pediatrics, 1997, 156(5):546-9.
11. Fernando S et al. Antibodies to HCV in patient who have has multiple transfusions in Sri Lanka. Acta paediatrica, 2001, 86:1135-7.
12. Wu JS et al. Genotype distribution of hepatitis C virus infection in Taiwan. Journal of medical virology, 1994, 44(1):74-9.
13. Pawlotsky JM et al. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. Journal of clinical microbiology, 1997, 35(7):1734-9.
14. Sibal A, Mishra D, Arora A. Hepatitis C in childhood. Journal of the Indian Medical Association, 2002, 100(2):93-8.
15. Mison LM et al. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population. Transfusion, 1997, 37:73-8.
16. Watson JP et al. Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients. Journal of hepatology, 1996, 25(5):599-607.
17. Skidmore S. Hepatitis C virus - epidemiology and serological diagnosis. Journal of medical microbiology, 1993, 39:321-2.
18. Simmonds P. Clinical prevalence of hepatitis C virus genotypes. Gut, 1997, 40:291-3.
19. Spiliopoulou M et al. Response to interferon alfa 2b therapy in multitransfused children with beta thalassaemia major and chronic hepatitis C. European journal of clinical microbiology and infectious diseases, 1999, 18:709-15.
20. Diamantis I et al. Genotype distribution of hepatitis C infection in Greece: correlation with different risk factors and response to interferon therapy. European journal of gastroenterology and hepatology, 1998, 10(1):75-9.
21. Ni YH et al. Hepatitis C viral infection in thalassaemic children: clinical and molecular studies. Pediatric research, 1996, 39(2):323-31.